These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 31295873)

  • 1. Mitochondrial Involvement in Cisplatin Resistance.
    Cocetta V; Ragazzi E; Montopoli M
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial-lysosomal crosstalk.
    Sheng J; Shen L; Sun L; Zhang X; Cui R; Wang L
    Cell Prolif; 2019 May; 52(3):e12609. PubMed ID: 31033054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance.
    Genovese I; Carinci M; Modesti L; Aguiari G; Pinton P; Giorgi C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
    Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
    Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Links between cancer metabolism and cisplatin resistance.
    Cocetta V; Ragazzi E; Montopoli M
    Int Rev Cell Mol Biol; 2020; 354():107-164. PubMed ID: 32475471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy.
    Kohno K; Wang KY; Takahashi M; Kurita T; Yoshida Y; Hirakawa M; Harada Y; Kuma A; Izumi H; Matsumoto S
    Int J Mol Sci; 2015 Aug; 16(8):19836-50. PubMed ID: 26307971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VDAC1 as a target in cisplatin anti-tumor activity through promoting mitochondria fusion.
    Luo L; Xiong Y; Jiang N; Zhu X; Wang Y; Lv Y; Xie Y
    Biochem Biophys Res Commun; 2021 Jun; 560():52-58. PubMed ID: 33971568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cell metabolism: Rewiring the mitochondrial hub.
    Oliveira GL; Coelho AR; Marques R; Oliveira PJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria Participate in Chemoresistance to Cisplatin in Human Ovarian Cancer Cells.
    Zampieri LX; Grasso D; Bouzin C; Brusa D; Rossignol R; Sonveaux P
    Mol Cancer Res; 2020 Sep; 18(9):1379-1391. PubMed ID: 32471883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer.
    Han Y; Cho U; Kim S; Park IS; Cho JH; Dhanasekaran DN; Song YS
    Free Radic Res; 2018 Dec; 52(11-12):1271-1287. PubMed ID: 29607684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial ClpP activity is required for cisplatin resistance in human cells.
    Zhang Y; Maurizi MR
    Biochim Biophys Acta; 2016 Feb; 1862(2):252-64. PubMed ID: 26675528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions.
    Marullo R; Werner E; Degtyareva N; Moore B; Altavilla G; Ramalingam SS; Doetsch PW
    PLoS One; 2013; 8(11):e81162. PubMed ID: 24260552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative Stress and Reprogramming of Mitochondrial Function and Dynamics as Targets to Modulate Cancer Cell Behavior and Chemoresistance.
    Falone S; Lisanti MP; Domenicotti C
    Oxid Med Cell Longev; 2019; 2019():4647807. PubMed ID: 31915507
    [No Abstract]   [Full Text] [Related]  

  • 16. ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics.
    Fan Z; Yu H; Cui N; Kong X; Liu X; Chang Y; Wu Y; Sun L; Wang G
    Exp Cell Res; 2015 Jul; 335(1):68-81. PubMed ID: 25936772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK/Parkin/mitophagy axis.
    Chen L; Liu L; Li Y; Gao J
    In Vitro Cell Dev Biol Anim; 2018 Jan; 54(1):1-10. PubMed ID: 29071589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and upcoming mitochondrial targets for cancer therapy.
    Kim HK; Noh YH; Nilius B; Ko KS; Rhee BD; Kim N; Han J
    Semin Cancer Biol; 2017 Dec; 47():154-167. PubMed ID: 28627410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer.
    Morisaki T; Katano M
    Curr Med Chem; 2003 Dec; 10(23):2517-21. PubMed ID: 14529467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin.
    Montopoli M; Bellanda M; Lonardoni F; Ragazzi E; Dorigo P; Froldi G; Mammi S; Caparrotta L
    Curr Cancer Drug Targets; 2011 Feb; 11(2):226-35. PubMed ID: 21158717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.